New Key Statistics Module, Z-Score and F-Score
AMEX:LCTX Key Ratios
| Market Cap $ M | 220.89 |
| Enterprise Value $ M | 188.35 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.23 |
| Price/Sales | 22.50 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 8.00 |
| EPS (TTM) $ | -0.12 |
| Beneish M-Score | 0.39 |
| 10-y EBITDA Growth Rate % | 16.30 |
| 5-y EBITDA Growth Rate % | 13.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -7.62 |
| EV-to-EBITDA | -7.83 |
| PEG | -- |
| Shares Outstanding M | 188.80 |
| Net Margin (%) | -240.20 |
| Operating Margin % | -276.50 |
| Pre-tax Margin (%) | -260.28 |
| Quick Ratio | 2.14 |
| Current Ratio | 2.14 |
| ROA % (ttm) | -19.33 |
| ROE % (ttm) | -30.87 |
| ROIC % (ttm) | -29.75 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.36 |
LCTX Number of Guru Trades
LCTX Volume of Guru Trades
Gurus Latest Trades with AMEX:LCTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:LCTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lineage Cell Therapeutics Inc Insider Transactions
No Available Data
News about AMEX:LCTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers